261 related articles for article (PubMed ID: 1674528)
1. Effects of dopamine receptor agonists and antagonists on catecholamine release in bovine chromaffin cells.
Huettl P; Gerhardt GA; Browning MD; Masserano JM
J Pharmacol Exp Ther; 1991 May; 257(2):567-74. PubMed ID: 1674528
[TBL] [Abstract][Full Text] [Related]
2. D2 dopamine receptors modulate calcium channel currents and catecholamine secretion in bovine adrenal chromaffin cells.
Bigornia L; Allen CN; Jan CR; Lyon RA; Titeler M; Schneider AS
J Pharmacol Exp Ther; 1990 Feb; 252(2):586-92. PubMed ID: 2156054
[TBL] [Abstract][Full Text] [Related]
3. Dopamine receptors on adrenal chromaffin cells modulate calcium uptake and catecholamine release.
Bigornia L; Suozzo M; Ryan KA; Napp D; Schneider AS
J Neurochem; 1988 Oct; 51(4):999-1006. PubMed ID: 2458437
[TBL] [Abstract][Full Text] [Related]
4. Glucagon does not affect catecholamine release in primary cultures of bovine adrenal chromaffin cells.
Sharabi Y; Zimlichman R; Alesci S; Huynh T; Mansouri R; Chun J; Perera S; Pacak K; Goldstein DS
Horm Metab Res; 2005 Apr; 37(4):205-8. PubMed ID: 15952078
[TBL] [Abstract][Full Text] [Related]
5. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies.
Hu XT; White FJ
Synapse; 1994 May; 17(1):43-61. PubMed ID: 7913772
[TBL] [Abstract][Full Text] [Related]
6. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
Wachtel SR; Hu XT; Galloway MP; White FJ
Synapse; 1989; 4(4):327-46. PubMed ID: 2532422
[TBL] [Abstract][Full Text] [Related]
7. Differential influence of D1 and D2 dopamine receptors on acute opiate withdrawal in guinea-pig isolated ileum.
Capasso A; Sorrentino L
Br J Pharmacol; 1997 Mar; 120(6):1001-6. PubMed ID: 9134209
[TBL] [Abstract][Full Text] [Related]
8. Dopamine receptor activation in bovine pinealocyte via a cAMP-dependent transcription pathway.
Santanavanich C; Ebadi M; Govitrapong P
J Pineal Res; 2005 Apr; 38(3):170-5. PubMed ID: 15725338
[TBL] [Abstract][Full Text] [Related]
9. Selective inhibition of cholinergic receptor-mediated 45Ca++ uptake and catecholamine secretion from adrenal chromaffin cells by taxol and vinblastine.
McKay DB; Schneider AS
J Pharmacol Exp Ther; 1984 Oct; 231(1):102-8. PubMed ID: 6149300
[TBL] [Abstract][Full Text] [Related]
10. Dopaminergic inhibition of catecholamine secretion from chromaffin cells: evidence that inhibition is mediated by D4 and D5 dopamine receptors.
Dahmer MK; Senogles SE
J Neurochem; 1996 Jan; 66(1):222-32. PubMed ID: 8522958
[TBL] [Abstract][Full Text] [Related]
11. Characterization of catecholamine release from deer adrenal medullary chromaffin cells.
Douglas SA; Stevenson KE; Knowles PJ; Bunn SJ
Neurosci Lett; 2008 Nov; 445(1):126-9. PubMed ID: 18775475
[TBL] [Abstract][Full Text] [Related]
12. Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum.
Onali P; Olianas MC; Gessa GL
Mol Pharmacol; 1985 Aug; 28(2):138-45. PubMed ID: 2410769
[TBL] [Abstract][Full Text] [Related]
13. Agonist-induced desensitization of D2 dopamine receptors in human Y-79 retinoblastoma cells.
Barton AC; Black LE; Sibley DR
Mol Pharmacol; 1991 May; 39(5):650-8. PubMed ID: 1674585
[TBL] [Abstract][Full Text] [Related]
14. Neurotransmitter release from bovine adrenal chromaffin cells is modulated by capacitative Ca(2+)entry driven by depleted internal Ca(2+)stores.
Zerbes M; Clark CL; Powis DA
Cell Calcium; 2001 Jan; 29(1):49-58. PubMed ID: 11133355
[TBL] [Abstract][Full Text] [Related]
15. Dual effect of digitalis glycosides on norepinephrine release from human atrial tissue and bovine adrenal chromaffin cells: differential dependence on [Na+]i and [Ca2+]i.
Haass M; Serf C; Gerber SH; Krüger C; Haunstetter A; Vahl CF; Nobiling R; Kübler W
J Mol Cell Cardiol; 1997 Jun; 29(6):1615-27. PubMed ID: 9220347
[TBL] [Abstract][Full Text] [Related]
16. Actions of A-75200, a novel catecholamine uptake inhibitor, on norepinephrine uptake and release from bovine adrenal chromaffin cells.
Firestone JA; Gerhardt GA; DeBernardis JF; McKelvy JF; Browning MD
J Pharmacol Exp Ther; 1993 Mar; 264(3):1206-10. PubMed ID: 8450458
[TBL] [Abstract][Full Text] [Related]
17. Effect of quinpirole, a specific dopamine DA2 receptor agonist on the sympathoadrenal system in dogs.
Damase-Michel C; Montastruc JL; Gharib C; Geelen G; De Saint-Blanquat G; Tran MA
J Pharmacol Exp Ther; 1990 Feb; 252(2):770-7. PubMed ID: 1968975
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological characterization of the receptor mediating electrophysiological responses to dopamine in the rat medial prefrontal cortex: a microiontophoretic study.
Sesack SR; Bunney BS
J Pharmacol Exp Ther; 1989 Mar; 248(3):1323-33. PubMed ID: 2564893
[TBL] [Abstract][Full Text] [Related]
19. Effects of alpha- and beta-adrenoceptor agonists and antagonists on ATP and catecholamine release and desensitization of the nicotinic response in bovine adrenal chromaffin cells.
Wan DC; Powis DA; Marley PD; Livett BG
Biochem Pharmacol; 1988 Feb; 37(4):725-36. PubMed ID: 3342103
[TBL] [Abstract][Full Text] [Related]
20. Neuropeptide Y inhibits the nicotine-mediated release of catecholamines from bovine adrenal chromaffin cells.
Higuchi H; Costa E; Yang HY
J Pharmacol Exp Ther; 1988 Feb; 244(2):468-74. PubMed ID: 3346832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
